The latest development in the toxic baby formula litigation is the solidification of the signature injury, the necrotizing enterocolitis in the infant. As discussed in previous blogs, multiple claims are being set forth from the plaintiffs at this point in litigation: design defect, failure to warn, and negligence.
The notice of appearance at the JPML Court is currently scheduled for February 2, 2022. On March 31, the JPML Clerk will conduct a formal hearing regarding the consolidation of cases.
Also, many cases have been filed in multiple districts, including the Northern District of Illinois, the District of Columbia, the Middle District of Louisiana, the Northern District of Florida, the Middle District of Florida, the Southern District of Texas, the Western District of Missouri, the Southern District of Illinois, and the Central District of California.
Finally, both defendants have asked for a stay of proceedings, as there has been minimal document production. They are asking for a stay until the JPML ruling in March. As new updates develop and more cases are filed into district courts, we will continue to take on cases here at the Michael Brady Lynch Firm.
If your child or a loved one has been injured by this toxic baby formula and has suffered necrotizing enterocolitis because of taking it, please call us at the Michael Brady Lynch Firm at 888-585-5970.
Ginglen, J.G. & Butki, N. Necrotizing Enterocolitis. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK513357/
U.S. Food and Drug Administration. Able Groupe Recalling Products Labeled as Infant Formula Formulas Have Insufficient Iron Levels as Per Requirements for Infant Formula in The U.S., and Products Do Not Meet Other FDA Requirements. Retrieved from https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/able-groupe-recalling-products-labeled-infant-formula-formulas-have-insufficient-iron-levels